IndustryCompany release

CVS Health raises 2026 guidance after third-quarter revenue climbs 5.4% to $108.4bn

🇺🇸 CVS HEALTH Corp (CVS) · Wed 04 Nov 2026

The US healthcare group lifted full-year profit and cash-flow forecasts, citing stronger performance in its insurance and pharmacy divisions, and flagged expanded GLP-1 weight management offerings.

CVS Health reported third-quarter 2026 results on 4 November, posting revenue of $108.4bn. The company reported GAAP earnings per share of $1.68 and adjusted earnings per share of $2.09.

Stronger performance in its Health Care Benefits segment, which includes Aetna, and in Pharmacy & Consumer Wellness led the company to raise its full-year guidance. The upgrade covers GAAP EPS, adjusted EPS and operating cash flow.

CVS also said that more than 69% of Aetna Medicare Advantage members are enrolled in 2027 plans rated 4 stars or higher by the Centers for Medicare & Medicaid Services (CMS). Star ratings are a quality measure that CMS uses for Medicare Advantage plans, and they can affect plan payments and bonuses.

The company additionally described expanded GLP-1 weight management offerings. The summary available does not give details of the programmes, the pricing or the products involved, and the full guidance figures were not available at the time of writing.

What it means for your team

  • Market-access teams should note that Aetna's Medicare Advantage star-rating position for 2027 is a key quality indicator for a major US payer.
  • The expansion of GLP-1 weight management offerings at a large pharmacy and benefits group may be relevant to access and utilisation planning for these products.
  • Details of the new GLP-1 offerings and the revised guidance ranges should be checked in CVS Health's full results materials before teams draw conclusions.

Company's press release (SEC filing): CVS HEALTH Corp ↗

Article written by VigiEye from the official source (CVS HEALTH Corp). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →